Company: United Therapeutics CorporationBloomberg ticker: USMarket cap: US$12,777mBackground: United Therapeutics Corporation develops pharmaceuticals to treat vascular diseases such as pulmonary hypertension and peripheral vascular disease. The Company’s lead products are stable synthetic forms of prostacyclin and are delivered orally or subcutaneously.
World Class Benchmarking of United Therapeutics Corp
(Click on image to enlarge)
More By This Author: